 |
| Neurodiagnostics Market |
Neurodiagnostics involves the diagnosis of neurological disorders and includes various technologies such as imaging, neuroelectrophysiology, neurobiological, and biomarkers. Neurodiagnostics provide non-invasive diagnosis of disorders through imaging technologies such as MRI and CT scans. They help identify conditions such as tumors, strokes, spinal cord injuries, and epilepsy. Increasing prevalence of neurological disorders such as Alzheimer’s, Parkinson’s, epilepsy, and brain aneurysms is driving demand for neurodiagnostic procedures.
The Global Neurodiagnostics Market is estimated to be valued at US$ 14.91 Bn in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period 2024 to 2031.Key Takeaways
Key players operating in the Neurodiagnostics are Koninklijke Philips N.V, Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, FUJIFILM Holdings Corporation, Bio-Rad Laboratories Inc., Advanced Brain Monitoring, Inc., Nihon Kohden Corporation, Mitsar Co. LTD., EMS Biomedical, Mennen Medical, Natus Medical Incorporated, Medicaid Systems, Fujirebio, FONAR Corp, ANT Neuro, NEUROLITE AG, and Atlantic Health System.
The key opportunities in the Neurodiagnostics Market Demand are increasing research and development activities to develop advanced neurodiagnostic technologies and rising investment and funding from government and private organizations for commercialization of neurodiagnostic devices.
The Asia Pacific region is poised to be the
fastest growing market during the forecast period. This is attributed to
factors such as rising healthcare spending, increasing disposable incomes,
growing incidence of neurological disorders due to lifestyle changes and aging
population. China and India are emerging as opportunistic markets with huge
patient bases. Improvements in the medical devices regulatory systems and
availability of skilled technicians will further support the neurodiagnostics
market growth in Asia Pacific.
The neurodiagnostics market involves detecting
or diagnosing neurological disorders through various techniques such as
imaging, testing, neuroendoscopy, and others. Neurological disorders like
epilepsy, Alzheimer's disease, Parkinson's disease, stroke, multiple sclerosis,
and migraine affect millions of people worldwide and their incidence is rising
owing to growing aging population and risk factors such as stress, lifestyle
changes, and environmental pollutants.
Neurodiagnostics help in analyzing the
nervous system function, structure, biochemistry, and related molecular mechanisms
to identify and track neurological conditions accurately. Some key advantages
of neurodiagnostics include early and precise disease diagnosis, pinpointing
abnormal brain regions, monitoring disease progression and treatment outcomes,
and enabling objective diagnosis to rule out subjective symptoms. The need for
neurodiagnostics is growing owing to increasing neurological patient population
requiring timely diagnosis and care.
Get more insights, On Neurodiagnostics
Market
Explore More On, Neurodiagnostics
Market
0 Comments